Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin

被引:137
作者
Nagy, A
Schally, AV
Halmos, G
Armatis, P
Cai, RZ
Csernus, V
Kovács, M
Koppán, M
Szepesházi, K
Kahán, Z
机构
[1] Vet Affairs Med Ctr, Inst Endocrine Polypeptide & Canc, New Orleans, LA 70146 USA
[2] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70146 USA
关键词
targeted chemotherapeutic agents; hybrid molecules; receptor binding; antiproliferative activity;
D O I
10.1073/pnas.95.4.1794
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
To create cytotoxic hybrid analogs of somatostatin (SST), octapeptides RC-160 (D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH2) and RC-121 (D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NB2) were linked to doxorubicin (DOX) or its superactive derivative, 2-pyrrolino-DOX (AN-201). The conjugation was performed by coupling N-9-fluorenylmethoxycarbonyl (N-Fmoc)-DOX-14-O-hemiglutarate or 2-pyrrolino-DOX-14-O-hemiglutarate to the amino terminus of [Lys(Fmoc)(5)]RC-160 yielding AN-163 and AN-258, respectively, after deprotection. The respective cytotoxic conjugates of RC-121 (AN-162 and AN-238) were prepared similarly, In vitro tests on human cancer cell lines-MKN-45 gastric cancer, MDA-MB-231 breast cancer, PC-3 prostate cancer, and MIA PaCa-2 pancreatic cancer-demonstrated that the antiproliferative activity of the cytotoxic radicals in these conjugates,vas virtually retained. In H-345 human small cell lung carcinoma cell line, conjugates of RC-121 preserved the cytotoxic activity of their radicals, but the hybrids with RC-160 showed approximate to 10 times lower activity. The ability of the carriers and the hybrids to inhibit the binding of I-125-labeled RC-160 to receptors for SST on rat pituitary membrane preparation was also determined. The cytotoxic conjugates inhibited 50% of the specific binding of the radioligand in the nanomolar concentration range (IC50 < 80 nM). When SST-like activities of AN-238 and its carrier, RC-121, were compared in the rat pituitary superfusion system, both compounds were found to suppress a stimulated growth hormone release at nanomolar concentrations. Preliminary studies in animal models of breast and prostate cancers showed that AN-238 is less toxic than AN-201 and more potent in inhibiting tumor growth. These highly active cytotoxic analogs of SST have been designed as targeted antitumor agents for the treatment of various cancers expressing receptors for SST octapeptides.
引用
收藏
页码:1794 / 1799
页数:6
相关论文
共 41 条
[1]   INVIVO APPLICATION OF [IN-111-DTPA-D-PHE1]-OCTREOTIDE FOR DETECTION OF SOMATOSTATIN RECEPTOR-POSITIVE TUMORS IN RATS [J].
BAKKER, WH ;
KRENNING, EP ;
REUBI, JC ;
BREEMAN, WAP ;
SETYONOHAN, B ;
DEJONG, M ;
KOOIJ, PPM ;
BRUNS, C ;
VANHAGEN, PM ;
MARBACH, P ;
VISSER, TJ ;
PLESS, J ;
LAMBERTS, SWJ .
LIFE SCIENCES, 1991, 49 (22) :1593-1601
[2]  
BAUER W, 1982, LIFE SCI, V31, P1133, DOI 10.1016/0024-3205(82)90087-X
[3]   HYPOTHALAMIC POLYPEPTIDE THAT INHIBITS SECRETION OF IMMUNOREACTIVE PITUITARY GROWTH-HORMONE [J].
BRAZEAU, P ;
VALE, W ;
BURGUS, R ;
LING, N ;
BUTCHER, M ;
RIVIER, J ;
GUILLEMIN, R .
SCIENCE, 1973, 179 (4068) :77-79
[4]   A NEW RADIOLABELED SOMATOSTATIN ANALOG [IN-111-DTPA-D-PHE(1)]RC-160 - PREPARATION, BIOLOGICAL-ACTIVITY, RECEPTOR SCINTIGRAPHY IN RATS AND COMPARISON WITH [IN-111-DTPA-D-PHE(1)]OCTREOTIDE [J].
BREEMAN, WAP ;
HOFLAND, LJ ;
VANDERPLUIJM, M ;
VANKOETSVELD, PM ;
DEJONG, M ;
SETYONOHAN, B ;
BAKKER, WH ;
KWEKKEBOOM, DJ ;
VISSER, TJ ;
LAMBERTS, SWJ ;
KRENNING, EP .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1994, 21 (04) :328-335
[5]   MOLECULAR PHARMACOLOGY OF SOMATOSTATIN-RECEPTOR SUBTYPES [J].
BRUNS, C ;
WECKBECKER, G ;
RAULF, F ;
KAUPMANN, K ;
SCHOEFFTER, P ;
HOYER, D ;
LUBBERT, H .
MOLECULAR AND CELL BIOLOGICAL ASPECTS OF GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR DISEASE, 1994, 733 :138-146
[6]   INHIBITION OF CELL-PROLIFERATION BY THE SOMATOSTATIN ANALOG RC-160 IS MEDIATED BY SOMATOSTATIN RECEPTOR SUBTYPES SSTR2 AND SSTR5 THROUGH DIFFERENT MECHANISMS [J].
BUSCAIL, L ;
ESTEVE, JP ;
SAINTLAURENT, N ;
BERTRAND, V ;
REISINE, T ;
OCARROLL, AM ;
BELL, GI ;
SCHALLY, AV ;
VAYSSE, N ;
SUSINI, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1580-1584
[7]   STIMULATION OF TYROSINE PHOSPHATASE AND INHIBITION OF CELL-PROLIFERATION BY SOMATOSTATIN ANALOGS - MEDIATION BY HUMAN SOMATOSTATIN RECEPTOR SUBTYPES SSTR1 AND SSTR2 [J].
BUSCAIL, L ;
DELESQUE, N ;
ESTEVE, JP ;
SAINTLAURENT, N ;
PRATS, H ;
CLERC, P ;
ROBBERECHT, P ;
BELL, GI ;
LIEBOW, C ;
SCHALLY, AV ;
VAYSSE, N ;
SUSINI, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) :2315-2319
[8]   SYNTHESIS AND BIOLOGICAL-ACTIVITY OF HIGHLY POTENT OCTAPEPTIDE ANALOGS OF SOMATOSTATIN [J].
CAI, RZ ;
SZOKE, B ;
LU, R ;
FU, D ;
REDDING, TW ;
SCHALLY, AV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (06) :1896-1900
[9]   Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5 [J].
Cordelier, P ;
Esteve, JP ;
Bousquet, C ;
Delesque, N ;
OCarroll, AM ;
Schally, AV ;
Vaysse, N ;
Susini, C ;
Buscail, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (17) :9343-9348
[10]  
CSERNUS V, 1991, NEUROENDOCRINE RES M, P66